Navigation Links
Micrus Endovascular to Webcast Fiscal 2007 Annual Meeting of Stockholders
Date:9/13/2007

SAN JOSE, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced that its fiscal 2007 Annual Meeting of Stockholders will be broadcast live over the Internet on Thursday, September 20, 2007 at 12:00 p.m. Eastern time (9:00 a.m. Pacific time). Those listening to the meeting via the live Internet broadcast will not have the opportunity to ask questions during the meeting.

What: Micrus Endovascular Fiscal 2007 Annual Meeting of Stockholders

When: Thursday, September 20, 2007 at 9:00 a.m. Pacific time

Where: http://www.micruscorp.com

How: Live over the Internet -- Log on to the Web at the address above

and go to the "Investor Relations" section of the Company's Web

site.

Contact: Brandi Floberg

Lippert/Heilshorn & Associates, Inc.

(310) 691-7100

If you are unable to participate during the live webcast, the webcast will be archived beginning approximately two hours following the event for 30 days on the Company's Web site http://www.micruscorp.com.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of neurovascular diseases. Micrus products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms responsible for hemorrhagic stroke, a significant cause of death worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory syst
'/>"/>

SOURCE Micrus Endovascular Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sonic Foundry to Webcast Bridge Arch Floating Down Mississippi
2. BoneCare doubles options and profits as fiscal year closes
3. Sonic Foundry Reports Fiscal 2003 Results
4. NameProtect releases annual list of top trademarkers
5. Doyle says new contracts saving state more than $16 million annually
6. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
7. Annual Bioethics Forum to explore genetic testing
8. Annual Conference Honors Tech Grant Winners
9. AG accuses BioCATT of violating meetings law
10. VC trends, company progress discussed at Mason Wells portfolio meeting
11. Beware the Dreaded Off-Site Technology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Cell Biosciences Acquires Protein Forest 2Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2
Breaking Biology News(10 mins):Improving the odds 2Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA 2Study shows nearly 1/3 of human genome is involved in gingivitis 2Study shows nearly 1/3 of human genome is involved in gingivitis 3Winners of the Addressing Psoriasis 28TM 29 Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn 50794 1Winners of the Addressing Psoriasis 28TM 29 Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn 50794 2Winners of the Addressing Psoriasis 28TM 29 Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn 50794 3Winners of the Addressing Psoriasis 28TM 29 Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn 50794 4Winners of the Addressing Psoriasis 28TM 29 Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn 50794 5Winners of the Addressing Psoriasis 28TM 29 Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn 50794 6Ready for relapse 3A Molecule helps breast cancer cells to survive in the bone marrow 50791 1Ready for relapse 3A Molecule helps breast cancer cells to survive in the bone marrow 50791 2Orange County Cosmetic Plastic Surgeon Reaches Out to Community with New Website 50787 1Orange County Cosmetic Plastic Surgeon Reaches Out to Community with New Website 50787 2Orange County Cosmetic Plastic Surgeon Reaches Out to Community with New Website 50787 3